Ferguson, Fleur M. http://orcid.org/0000-0003-4091-7617
Article History
First Online: 13 November 2023
Competing interests
: F.M.F. is a scientific co-founder and equity holder in Proximity Therapeutics, was recently a scientific advisory board (SAB) member for Triana Biomedicines, and is or recently was a consultant or received speaking honoraria from Eli Lilly and Co., RA Capital, Tocris BioTechne, Johnson & Johnson Innovative Medicine and Plexium Inc. The Ferguson lab receives or has received research funding from Ono Pharmaceutical Co. Ltd and Merck & Co.